POET Technologies: Award Nod and Production Ambitions Overshadowed by Customer Defection and Sector Rout

POET's Blazar laser platform gains industry recognition, but a $5M order cancellation by Marvell and a 37% stock drop overshadow its $500M Lumilens deal and 2026 production ramp.

The optics specialist POET Technologies finds itself in an uncomfortable spot: its Blazar laser platform has been shortlisted for the “Best Optical Component Innovation” prize at the ECOC Exhibition Awards in Malaga on 21 September, yet the stock closed at €6.52 on Friday, down 2.83% on the day and 37.67% lower over the past 30 days. The share now trades 65.39% below the May high of €18.84, though it still sits 91.76% above the November trough of €3.40. The relative strength index of 36 points to oversold territory, though that alone rarely signals a lasting reversal.

Investor confidence has been shaken by a concrete commercial blow that goes well beyond the broad semiconductor sell-off. In late April, Marvell — which had acquired POET customer Celestial AI — cancelled all outstanding orders, citing a confidentiality breach by POET CFO Thomas Mika. That scuttled a $5 million production order and ongoing billing that had served as a key reference for POET’s 800G optical engine progress. The cancellation landed in the same week that POET was already locked in a public war of words with Wolfpack Research, which had labelled the company an equity promotion with seven business model pivots and cumulative revenue of just $2.3 million since 2020. Mika pushed back forcefully in an interview, calling short sellers “maggots” and dismissing PFIC tax warnings as a “nothing burger,” while pledging to supply QEF election data for 2025 and relocate the corporate domicile to the US. The stock initially jumped 18% on that pushback, but the Marvell cancellation swiftly erased any relief.

The broader backdrop has done POET no favours. The Philadelphia Semiconductor Index slid roughly 18% in July, entering bear-market territory and posting its worst weekly loss in over a year. With an annualised 30-day volatility of about 101%, POET remains one of the most whipsaw-prone names in the photonics space, and the sector-wide rout has amplified its downward momentum.

None of this changes the operational story that POET continues to build. The Blazar nomination underlines the company’s role as an external light source for AI networks and hyperscale data centres, with a broad commercial deployment pencilled in for 2028. On the production front, POET confirmed in late June that optical engine manufacturing will begin in the second half of 2026, with a target to expand capacity to one million units per month by the end of 2027 — a tenfold increase from current levels. To fund that ramp, the company raised roughly $830 million through equity last year, with an initial $50 million earmarked for new fabrication equipment in H2 2026. More than ten active customer projects are now under way, collectively expected to yield over $100 million in annual revenue. The largest single commitment comes from Lumilens: a firm $50 million initial order for optical engines, plus a framework agreement targeting more than $500 million in cumulative revenue over five years, subject to pending development and qualification milestones. POET also plans to add around 50 employees in the coming months to handle the expansion.

The market’s focus, however, is squarely on whether the commercial pipeline can absorb the loss of the Marvell-derived business. The next checkpoint arrives on 10 August, when POET reports second-quarter results before the open. Analysts are looking for a loss of $0.08 per share on revenue of just $0.5 million. With the Celestial AI orders gone and the short-seller allegations still hanging in the air, the conference call on 12 August will need to show that the production ramp is translating into real orders — or risk giving the bears further ammunition.